Brief: China Pharma Holdings reports Q3 loss per share $0.05
15/11/2017 11:00
Nov 15 (Reuters) - China Pharma Holdings Inc CPHI.A
* China Pharma Holdings, Inc. reports third quarter 2017
financial
results
* Q3 loss per share $0.05
* Q3 revenue $3.2 million
* China Pharma Holdings - reform of China's drug production
registration and review policies to have "major impacton future
development of our industry"
* China Pharma Holdings - ongoing generic drug consistency
evaluations to also impact future development of co's industry,
may change its business patterns
Source text for Eikon: ID:nPn8B8CRta
Further company coverage: CPHI.A
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China Pharma Holdings
See all newsBrief: China Pharma - Not Aware Of Any Material Corporate Developments Explaining Recent Market Activity
Brief: China Pharma Says Co Knows Of No Events That Could Have Caused Unusual Market Activity
Brief: China Pharma Holdings Inc - NYSE American Contacts China Pharma Regarding Unusual Market Activity On May 12 And 13
Brief: China Pharma Holdings Files For Non-Timely 10-K With US SEC
Brief: China Pharma Holdings Inc. Announces 1-For-10 Reverse Stock Split